谢川, 吕农华. 中国幽门螺杆菌感染的现状[J]. 疾病监测, 2018, 33(4): 272-275. DOI: 10.3784/j.issn.1003-9961.2018.04.004
引用本文: 谢川, 吕农华. 中国幽门螺杆菌感染的现状[J]. 疾病监测, 2018, 33(4): 272-275. DOI: 10.3784/j.issn.1003-9961.2018.04.004
Xie Chuan, Lyu Nonghua. Helicobacter pylori infection in China[J]. Disease Surveillance, 2018, 33(4): 272-275. DOI: 10.3784/j.issn.1003-9961.2018.04.004
Citation: Xie Chuan, Lyu Nonghua. Helicobacter pylori infection in China[J]. Disease Surveillance, 2018, 33(4): 272-275. DOI: 10.3784/j.issn.1003-9961.2018.04.004

中国幽门螺杆菌感染的现状

Helicobacter pylori infection in China

  • 摘要: 我国是幽门螺杆菌(HP)高感染地区,HP感染相关疾病负担(尤其是胃癌)较重,国内学术界应尽快统一认识,重视HP感染的危害,建立有效的胃癌一、二级预防体系;同时,随着近年来抗生素耐药率的不断上升,传统方案根除率逐年下降,临床医师应参照最新共识,规范HP感染的诊治,重视提高初次HP根除率。

     

    Abstract: Helicobacter pylori infection rate is high in China,and the burden of H. pylori related diseases(especially gastric cancer)is heavy. The domestic academia should unify the understanding of harm of H. pylori infection as soon as possible,and establish effective primary or secondary prevention systems for gastric cancer. The H. pylori eradication rate with traditional methods is declining year by year along with the increasing rate of antibiotic resistance in recent years. Clinicians should standardize the diagnosis and treatment of H. pylori infection and make effort to increase primary H. pylori eradication rate based on the latest consensus in this field.

     

/

返回文章
返回